TwinPharma contributes to improve the health care in the Netherlands, Belgium and Luxembourg.

We do this by introducing added value medicines that up to now were not available in these countries.

Read more
Hepatect CP
Hepatect CP contains mainly IgG with a specifically high content of antibodies against hepatitis B virus surface antigen.
Read more
Hepatect
Megalotect 100 E/ml
Megalotect 100 E/ml is an immunoglobulin preparation from plasma of donors with a high antibody titer against the cytomegalovirus.
Read more
Hepatect
Zutectra
Prevention of hepatitis B virus re-infection in HBsAg and HBV-DNA negative adult patients at least one week after liver transplantation for hepatitis B induced liver failure.
Read more Belgium
Hepatect
Advies & Interim
Open positions, replacement or extra activities? TwinPharma can offer a solution.
Read more
50 million europeans

Are you looking for a distributor of medicines in Europe?

TwinPharma and Anthrop Pharmaceuticals joined forces and reaching out to more than 50 million Europeans in 7 countries.

Read more

Local Dutch-Belgian full service consultancy market access chain

Achieving reimbursement and price are the 2 most important drivers for a successful launch of an innovative medicine in the Netherlands and Belgium.
TwinPharma is working in a network with specialised partners in market access, pricing, pharmaco-economics, regulatory and KOL-management in the Netherlands and Belgium.

Read more
© TwinPharma All rights reserved.